Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Topical sensitizers have mixed success in treating alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

A man developed severe skin reactions after using a treatment for hair loss.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Topical tacrolimus is effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

DPCP treatment for alopecia areata can sometimes cause vitiligo.